Prelude Capital Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
2019
Q3
$23.3M Buy
2019
Q2
$24M Buy
2019
Q1
$12M Buy
2018
Q4
Sell
2018
Q3
$6K Buy
2017
Q4
Sell
2017
Q3
$198K Sell
2017
Q2
$322K Buy
2015
Q4
Sell
2015
Q3
$153K Hold
2015
Q2
$222K Buy